These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9648535)
1. Duck hepatitis B virus inactivation and 8-methoxypsoralen photoadduct formation in human platelet concentrates. Eble BE; Corash L Photochem Photobiol; 1998 Jun; 67(6):700-13. PubMed ID: 9648535 [TBL] [Abstract][Full Text] [Related]
2. Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: a model of surrogate human hepatitis B virus infectivity. Eble BE; Corash L Transfusion; 1996 May; 36(5):406-18. PubMed ID: 8693504 [TBL] [Abstract][Full Text] [Related]
3. Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates. Corash L; Lin L; Wiesehahn G Blood Cells; 1992; 18(1):57-73; discussion 74. PubMed ID: 1617193 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination. Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098 [TBL] [Abstract][Full Text] [Related]
5. Validation of biocides against duck hepatitis B virus as a surrogate virus for human hepatitis B virus. Sauerbrei A; Schacke M; Glück B; Egerer R; Wutzler P J Hosp Infect; 2006 Dec; 64(4):358-65. PubMed ID: 17011665 [TBL] [Abstract][Full Text] [Related]
6. Alternative methods for validation of cell culture infection with duck hepatitis B virus. Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Grass JA; Hei DJ; Metchette K; Cimino GD; Wiesehahn GP; Corash L; Lin L Blood; 1998 Mar; 91(6):2180-8. PubMed ID: 9490707 [TBL] [Abstract][Full Text] [Related]
8. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen. Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361 [TBL] [Abstract][Full Text] [Related]
9. Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates. Lin L; Londe H; Hanson CV; Wiesehahn G; Isaacs S; Cimino G; Corash L Blood; 1993 Jul; 82(1):292-7. PubMed ID: 8324230 [TBL] [Abstract][Full Text] [Related]
10. Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Lin L; Londe H; Janda JM; Hanson CV; Corash L Blood; 1994 May; 83(9):2698-706. PubMed ID: 8167348 [TBL] [Abstract][Full Text] [Related]
11. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes]. Yao Y; Tang N; Huang A Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700 [TBL] [Abstract][Full Text] [Related]
12. [Effect of antioxidants on photoaddition of 8-methoxypsoralen to thymine, double-helix DNA and photosensitized inactivation of Escherichia coli]. Potapenko AIa; Moshnin MV; Abyev GA; Gerashchenko PG; Belikov NG Biofizika; 1982; 27(6):995-9. PubMed ID: 6760905 [TBL] [Abstract][Full Text] [Related]
13. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner. Miller DS; Kotlarski I; Jilbert AR Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364 [TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection. Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204 [TBL] [Abstract][Full Text] [Related]
15. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling]. Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531 [TBL] [Abstract][Full Text] [Related]
16. Antiviral effects of PNA in duck hepatitis B virus infection model. Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953 [TBL] [Abstract][Full Text] [Related]
17. Enhanced duck hepatitis B virus gene expression following aflatoxin B1 exposure. Barraud L; Guerret S; Chevallier M; Borel C; Jamard C; Trepo C; Wild CP; Cova L Hepatology; 1999 Apr; 29(4):1317-23. PubMed ID: 10094981 [TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. Han YQ; Huang ZM; Yang XB; Liu HZ; Wu GX J Ethnopharmacol; 2008 Jun; 118(1):148-53. PubMed ID: 18495393 [TBL] [Abstract][Full Text] [Related]
19. Preferential repair incision of cross-links versus monoadducts in psoralen-damaged plasmid DNA by human cell-free extracts. Calsou P; Sage E; Moustacchi E; Salles B Biochemistry; 1996 Nov; 35(47):14963-9. PubMed ID: 8942662 [TBL] [Abstract][Full Text] [Related]
20. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]